Metis TechBio Co., Ltd. Class H's next confirmed earnings release is scheduled for March 3, 2027.
| Earnings Date | 3/3/2027 |
As of December 31, 2025, Metis TechBio Co., Ltd. Class H has 1.15B shares outstanding.
| Shares Outstanding | 1.15B |
As of December 31, 2025, Metis TechBio Co., Ltd. Class H maintains a current ratio of 6.67, meaning it holds 6.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.67 |
| Quick Ratio | 6.54 |
| Debt / Equity | 12.60 |
Over the twelve months ended December 31, 2025, Metis TechBio Co., Ltd. Class H recorded 13,997.15 in income tax expense.
| Income Tax | 13,997.15 |
As of December 31, 2025, Metis TechBio Co., Ltd. Class H holds 136.99M in cash and equivalents against 15.96M in total debt, resulting in a net debt position of -95.94M. Total book value stands at 126.69M, with working capital of 118.88M providing operational flexibility.
| Cash & Cash Equivalents | 136.99M |
| Total Debt | 15.96M |
| Net Debt | -95.94M |
| Equity (Book Value) | 126.69M |
| Book Value Per Share | 0.11 |
| Working Capital | 118.88M |
These figures cover the twelve months ended December 31, 2025.
| Capital Expenditures | -778,485.20 |
Already premium?